We are monitoring the impact of COVID-19 on APAC HPAPI Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific High Potency API Market Research Report – Segmented By Type, Synthesis, Therapeutic Application & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2904
Pages: 145

APAC HPAPI Market Size (2022 to 2027)

The size of the Asia Pacific High Potency APIs Market was valued at USD 4.52 billion in 2022. It is further estimated to be growing at a CAGR of 9.1% and worth USD 6.98 billion by 2027.

High Potency Active Pharmaceutical Ingredients (HPAPI) are a group of pharmacological substances and intermediates, active at concentrations of 150 micrograms per kilogram of body weight or below. They are characterized by high specificity, so they can bind to specific receptors or specific enzymes, which can cause cancer, reproductive problems, and developmental disorders at low doses. The growth of this market is high as many new drugs have these HPAPI’s.

High Potency Active Pharmaceutical Ingredients gave rise to alternative methods of treatment by different drugs, notably cancer. After the human genome mapping, new drugs for cancer could be made not only for different cancers but also for different patients. Their production is to be done with great care since they are active even at low concentrations. They can pose grave consequences to workers if proper care is not taken during production. Special care has to be taken to prevent contamination of drugs with contaminants. So, it requires specialized equipment for handling HPAPI’s and managing air quality.

The Asia-Pacific High Potency Active Pharmaceutical Ingredients market has driving factors such as low price, growing government initiatives to increase generic medicines' usage to cut down healthcare costs, growing healthcare prices, rising number of pharmaceutical manufacturers and patients.

However, the market is constrained by factors like the lack of skilled workers, stringent regulatory requirements, and equipment's high price.

This research report on the Asia Pacific HPAPI Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Innovative HPAPI's
  • Generic HPAPI's

By Synthesis: 

  • Biotech HPAPI's
  • Synthetic HPAPI's

By Therapeutic Application: 

  • Oncology
  • Glaucoma
  • Hormonal Balance

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the Asia Pacific region is expected to be the fastest-growing region in the world. Factors such as increased funding for cancer research, the rising number of people diagnosed with cancer, and approval for the production of new drugs will boost the growth of this market in the region.

Promising companies leading the APAC High Potency API (HPAPI) Market Profiled in the Report are Pfizer, Inc. (U.S.), Novartis International AG (Switzerland), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Boehringer Ingelheim (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co., Inc. (U.S.), AbbVie Inc. (U.S.), and Mylan Inc. (U.S.).

1.Introduction                           

               1.1 Market Definition              

               1.2 Study Deliverables             

               1.3 Base Currency, Base Year and Forecast Periods                     

               1.4 General Study Assumptions            

2. Research Methodology

               2.1 Introduction         

               2.2 Research Phases                

                              2.2.1 Secondary Research      

                              2.2.2 Primary Research                                

                              2.2.3 Econometric Modelling

                              2.2.4 Expert Validation                                 

               2.3 Analysis Design                   

               2.4 Study Timeline                    

3. Overview                               

               3.1 Executive Summary           

               3.2 Key Inferences                    

               3.3 Epidemology                       

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                  

               4.1 Market Drivers                   

               4.2 Market Restraints              

               4.3 Key Challenges                   

               4.4 Current Opportunities in the Market           

5. Market Segmentation                        

               5.1 Type                       

                              5.1.1 Innovative HPAPI's                              

                              5.1.2 Generic HPAPI's                                   

                              5.1.3  Y-o-Y Growth Analysis, By Type

                              5.1.4  Market Attractiveness Analysis, By Type

                              5.1.5  Market Share Analysis, By Type

               5.2 Synthesis               

                              5.2.1 Biotech HPAPI's                                   

         5.2.1.1 Biotech High- otency Active Pharmaceutical Ingredients Market, By Type               

                        5.2.1.1.1 Innovative Biotech HPAPIs         

                        5.2.1.1.2 Biosimilars       

                              5.2.2 Synthetic HPAPI's                                

         5.2.2.1 Synthetic High Potency Active Pharmaceutical Ingredients Market, By Type              

                        5.2.2.1.1 Innovative Synthetic HPAPIs      

                        5.2.2.1.2 Generic Synthetic HPAPIs           

                              5.2.3 Y-o-Y Growth Analysis, By Synthesis        

                              5.2.4 Market Attractiveness Analysis, By Synthesis        

                              5.2.5 Market Share Analysis, By Synthesis        

               5.3 Therapeutic Application                  

                              5.3.1 Oncology                               

                              5.3.2 Glaucoma                              

                              5.3.3 Hormonal Balance                              

                              5.3.4 Other therapeutic applications  

                              5.3.5 Y-o-Y Growth Analysis, By Therapeutic Application                                 

                              5.3.6  Market Attractiveness Analysis, By Therapeutic Application                               

                              5.3.7  Market Share Analysis, By Therapeutic Application                                

               5.4 Manufacturer                     

                              5.4.1 Captive Manufacturers 

                              5.4.2 Merchant Manufacturers                                 

         5.4.2.1 Merchant HPAPI Manufacturers Market, By Type                 

                        5.4.2.1.1 Innovative Merchant HPAPI Manufacturers         

                        5.4.2.1.2 Generic Merchant HPAPI Manufacturers              

         5.4.2.2 Merchant HPAPI Manufacturers Market, By Type of Synthesis                             

                        5.4.2.2.1 Synthetic HPAPIs           

                        5.4.2.2.2 Biotech HPAPIs              

                              5.4.3 Y-o-Y Growth Analysis, By Manufacturer

                              5.4.4  Market Attractiveness Analysis, By Manufacturer                                  

                              5.4.5  Market Share Analysis, By Manufacturer                                   

6. Geographical Analysis                        

               6.1 Introduction         

                              6.1.1 Regional Trends                                   

                              6.1.2 Impact Analysis

                              6.1.3 Y-o-Y Growth Analysis   

         6.1.3.1 By Type                

         6.1.3.2 By Synthesis                       

         6.1.3.3 By Therapeutic Application                           

         6.1.3.4 By Manufacturer               

                              6.1.4  Market Attractiveness Analysis 

         6.1.4.1 By Type                

         6.1.4.2 By Synthesis                       

         6.1.4.3 By Therapeutic Application                           

         6.1.4.4  By Manufacturer                             

                              6.1.5  Market Share Analysis  

         6.1.5.1 By Type                

         6.1.5.2 By Synthesis                       

         6.1.5.3 By Therapeutic Application                           

         6.1.5.4 By Manufacturer               

               6.2 China                     

               6.3 India                      

               6.4 Japan                     

               6.5 South Korea         

               6.6 Australia               

7.Strategic Analysis                                 

               7.1 PESTLE analysis                  

                              7.1.1 Political                                  

                              7.1.2 Economic                               

                              7.1.3 Social  

                              7.1.4 Technological  

                              7.1.5 Legal   

                              7.1.6 Environmental 

               7.2 Porter’s Five analysis        

                              7.2.1 Bargaining Power of Suppliers   

                              7.2.2 Bargaining Power of Consumers                                   

                              7.2.3 Threat of New Entrants

                              7.2.4 Threat of Substitute Products and Services                                

                              7.2.5 Competitive Rivalry within the Industry  

8.Market Leaders' Analysis                                   

               8.1 Pfizer Inc.             

                              8.1.1 Overview                                

                              8.1.2 Product Analysis                                  

                              8.1.3 Financial analysis                                 

                              8.1.4 Recent Developments   

                              8.1.5 SWOT analysis 

                              8.1.6 Analyst View     

               8.2 Novartis International AG               

               8.3 Sanofi                    

               8.4 F. Hoffmann-La Roche Ltd.            

               8.5 Eli Lilly and Company                       

               8.6 Bristol-Myers Squibb                        

               8.7 Boehringer Ingelheim                      

               8.8 Teva Pharmaceutical Industries Ltd.            

               8.9 Merck & Co., Inc.               

               8.10 AbbVie Inc.                        

               8.11 Mylan Inc.          

9.Competitive Landscape 

               9.1 Market share analysis                      

               9.2 Merger and Acquisition Analysis                   

               9.3 Agreements, collaborations and Joint Ventures                     

               9.4 New Product Launches                    

10.Market Outlook and Investment Opportunities  

Appendix

               a) List of Tables          

               b) List of Figures        

  1. Asia-Pacific High Potency Active Pharmaceutical Ingredients Market, By Type, From 2022 - 2027 (USD Million)
  2. Asia-Pacific Innovative HPAPI's  Market, By Region, From 2022 - 2027 (USD Million)
  3. Asia-Pacific Generic HPAPI's Market, By Region, From 2022 - 2027 (USD Million)
  4. Asia-Pacific High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2022 - 2027 (USD Million)
  5. Asia-Pacific Biotech HPAPI's Market, By Region, From 2022 - 2027 (USD Million)
  6. Asia-Pacific Synthetic HPAPI's Market, By Region, From 2022 - 2027 (USD Million)
  7. Asia-Pacific High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2022 - 2027 (USD Million)
  8. Asia-Pacific Oncology Market, By Region, From 2022 - 2027 (USD Million)
  9. Asia-Pacific Glaucoma Market, By Region, From 2022 - 2027 (USD Million)
  10. Asia-Pacific Hormonal Balance Market, By Region, From 2022 - 2027 (USD Million)
  11. Asia-Pacific other therapeutic applications Market, By Region, From 2022 - 2027 (USD Million)
  12. Japan High Potency Active Pharmaceutical Ingredients Market, By Type, From 2022 - 2027 (USD Million)
  13. Japan High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2022 - 2027 (USD Million)
  14. Japan High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2022 - 2027 (USD Million)
  15. China High Potency Active Pharmaceutical Ingredients Market, By Type, From 2022 - 2027 (USD Million)
  16. China High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2022 - 2027 (USD Million)
  17. China High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2022 - 2027 (USD Million)
  18. India High Potency Active Pharmaceutical Ingredients Market, By Type, From 2022 - 2027 (USD Million)
  19. India High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2022 - 2027 (USD Million)
  20. India High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2022 - 2027 (USD Million)
  21. Australia High Potency Active Pharmaceutical Ingredients Market, By Type, From 2022 - 2027 (USD Million)
  22. Australia High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2022 - 2027 (USD Million)
  23. Australia High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2022 - 2027 (USD Million)
  24. South Korea High Potency Active Pharmaceutical Ingredients Market, By Type, From 2022 - 2027 (USD Million)
  25. South Korea High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2022 - 2027 (USD Million)
  26. South Korea High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample